Within the framework of its separation process from General Electric (GE), GE Healthcare -the medical technology business- unveiled the future of the company with its regional strategy and announced that as of January 2023 it will be listed on the nasdaq.
During a statement, it was specified that the company will begin to operate as an independent from the first week of January next year and will be listed on the Nasdaq under the symbol “GEHC”.
“The company leads the health care equipment sector in Latin America, with 4,000 employees in the region and more than 250,000 installed pieces of equipment. In addition, it has three manufacturing plants in Brazil and Mexico, which allow it to provide the most recent technological innovations in the sector through public and private clients.“, he pointed.
In addition, he stressed that GE HealthCare will seek to create a world where medical care and health care have no limits. To do this, it will aim to drive innovations to offer better results to patients and clients.
“Latin America represents close to 5% of current billing globally and approximately 25% of the intercontinental region, meaning a key market in the company’s global strategy. As the post-COVID-19 pandemic situation normalizes, we have seen potential for double-digit growth from its current level in the coming years.”, said Rafael Palombini, president and CEO of GE Healthcare Latin America.
He added that the company will focus this strategy on numerous competitive advantages that it has within the health industry such as: a world market of US$ 84,000 million that will grow between 4% and 6% per year until 2025.
In addition, Palombini noted that there will be 9,700 engineers and scientists focused on research and development around the world, and a global installed base of more than 4 million medical devices and more than 200 software applications that drive advances in clinical information.
For her part, Carla Maranca, executive director of GE Healthcare CALA (Central Area of Latin America), said that in recent years the company has gone from being an equipment provider to a health partner.
“This is a total revamp of our business in the region and we now provide customized solutions to different needs related to precision, efficiency, productivity and scale. We currently offer a larger portfolio, with hardware, software, consulting, financing and service solutions to support sustainable growth in Latin America in general.”, he added.
Separation
In November 2021, GE announced that it will split into three separate companies focused on precision healthcare, the future of aviation, and guiding the energy transition.
In July 2022, the new names of the independent brands were specified: GE HealthCare for GE’s medical equipment firm, the energy portfolio – which includes GE Renewable Energy, GE Power, GE Digital and GE Energy Financial Services – joins under GE Vernova, and the aviation business is called GE Aerospace.
He said the three envisioned companies will continue to benefit from GE’s global brand and heritage, valued at about $20 billion.
